Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 139 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development.
Feemster K, Hausdorff WP, Banniettis N, Platt H, Velentgas P, Esteves-Jaramillo A, Burton RL, Nahm MH, Buchwald UK
Vaccines (Basel), 12(9):974, 28 Aug 2024
Cited by: 0 articles | PMID: 39340006 | PMCID: PMC11435891
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.
Feng S, McLellan J, Pidduck N, Roberts N, Higgins JP, Choi Y, Izu A, Jit M, Madhi SA, Mulholland K, Pollard AJ, Procter S, Temple B, Voysey M
Health Technol Assess, 28(34):1-109, 01 Jul 2024
Cited by: 0 articles | PMID: 39046101
Add to export list ReviewBooks & documents
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Anticipated Effects of Higher-valency Pneumococcal Conjugate Vaccines on Colonization and Acute Otitis Media.
Kaur R, Schulz S, Sherman A, Andrejko K, Kobayashi M, Pichichero M
Pediatr Infect Dis J, 43(10):1004-1010, 05 Jun 2024
Cited by: 0 articles | PMID: 38838209 | PMCID: PMC11408086
Add to export list Free full text in Europe PMC
Immunogenicity of Current and Next-Generation Pneumococcal Conjugate Vaccines in Children: Current Challenges and Upcoming Opportunities.
Feemster K, Buchwald UK, Banniettis N, Joyce JG, Velentgas P, Chapman TJ, Yildirim I
Open Forum Infect Dis, 11(5):ofae220, 06 May 2024
Cited by: 0 articles | PMID: 38770212 | PMCID: PMC11103622
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Immunogenicity and seroefficacy of 10-valent and 13-valent pneumococcal conjugate vaccines: a systematic review and network meta-analysis of individual participant data.
Feng S, McLellan J, Pidduck N, Roberts N, Higgins JPT, Choi Y, Izu A, Jit M, Madhi SA, Mulholland K, Pollard AJ, Temple B, Voysey M
EClinicalMedicine, 61:102073, 01 Jul 2023
Cited by: 0 articles | PMID: 37425373 | PMCID: PMC10328810
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults.
LeFevre I, Bravo L, Folschweiller N, Medina EL, Moreira ED, Nordio F, Sharma M, Tharenos LM, Tricou V, Watanaveeradej V, Winkle PJ, Biswal S
NPJ Vaccines, 8(1):75, 25 May 2023
Cited by: 0 articles | PMID: 37230978 | PMCID: PMC10208910
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
[The new 15-valent pneumococcal conjugate vaccine for the prevention of S. pneumoniae infections in pediatric age: a Health Technology Assessment].
Calabrò GE, Vitale F, Rizzo C, Pugliese A, Boccalini S, Bechini A, Panatto D, Amicizia D, Domnich A, Amodio E, Costantino C, DI Pietro ML, Salvati C, D'Ambrosio F, Orsini F, Maida A, Dominici A, Clemente D, Cecci M, [...] DE Waure C
J Prev Med Hyg, 64(1 suppl 1):E1-E160, 01 Mar 2023
Cited by: 1 article | PMID: 37655211 | PMCID: PMC10468156
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Validation of an FFF-MALS Method to Characterize the Production and Functionalization of Outer-Membrane Vesicles for Conjugate Vaccines.
van der Put RMF, Spies A, Metz B, Some D, Scherrers R, Pieters R, Danial M
Anal Chem, 94(35):12033-12041, 25 Aug 2022
Cited by: 0 articles | PMID: 36007249 | PMCID: PMC9453738
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A cost-effectiveness analysis of PHiD-CV compared to PCV13 in a national immunization program setting in Tunisia.
Lagoubi Y, Sfar MT, Gomez JA
Hum Vaccin Immunother, 18(5):2079305, 15 Jun 2022
Cited by: 0 articles | PMID: 35703731 | PMCID: PMC9481096
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Immunogenicity of Conjugated and Polysaccharide Pneumococcal Vaccines Administered During Pregnancy or Postpartum to Women With HIV.
Duarte G, Muresan P, Ward S, Laimon L, Pelton SI, Canniff J, Golner A, Bone F, Newton L, Fenton T, Coutinho CM, João EC, Santos BR, Pilotto JH, Oliveira RH, Pinto JA, Machado ES, Kreitchman R, Chakhtoura N, [...] Weinberg A
J Infect Dis, 225(6):1021-1031, 01 Mar 2022
Cited by: 3 articles | PMID: 34791324 | PMCID: PMC8921998
Add to export list Free full text in Europe PMC
Immunogenicity of alternative ten-valent pneumococcal conjugate vaccine schedules in infants in Ho Chi Minh City, Vietnam: results from a single-blind, parallel-group, open-label, randomised, controlled trial.
Licciardi PV, Temple B, Dai VTT, Toan NT, Uyen D, Nguyen CD, Phan TV, Bright K, Marimla RA, Balloch A, Huu TN, Mulholland K
Lancet Infect Dis, 21(10):1415-1428, 23 Jun 2021
Cited by: 11 articles | PMID: 34171233 | PMCID: PMC8461081
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Cost-Effectiveness and Budget Impact Analyses of Pneumococcal Vaccination in Indonesia.
Suwantika AA, Zakiyah N, Abdulah R, Sitohang V, Tandy G, Anartati A, Hidayatullah T, Herliana P, Hadinegoro SR
J Environ Public Health, 2021:7494965, 27 Apr 2021
Cited by: 3 articles | PMID: 33995536 | PMCID: PMC8096558
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine for children in Taiwan.
Lu CY, Chung CH, Huang LM, Kruger E, Tan SC, Zhang XH, Chiu NC
Cost Eff Resour Alloc, 18:30, 28 Aug 2020
Cited by: 3 articles | PMID: 32874139 | PMCID: PMC7456386
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
How Basic Immunological Principles May Instruct the Design of a Successful HIV-Type 1 Vaccine.
Slobod KS, Hurwitz JL
Viral Immunol, 33(3):233-236, 01 Apr 2020
Cited by: 0 articles | PMID: 32286171 | PMCID: PMC7185311
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Cost-effectiveness of childhood pneumococcal vaccination program in Ethiopia: results from a quasi-experimental evaluation.
Kebede TT, Svensson M, Addissie A, Trollfors B, Andersson R
BMC Public Health, 19(1):1078, 09 Aug 2019
Cited by: 9 articles | PMID: 31399030 | PMCID: PMC6688319
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Spatial analysis of pneumococcal meningitis in São Paulo in the pre- and post-immunization era.
Oliveira DS, Chiaravalloti Neto F, Mota TS, Araujo DB, Sartori AMC
Rev Saude Publica, 53:59, 18 Jul 2019
Cited by: 2 articles | PMID: 31340351 | PMCID: PMC6629289
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Immunogenicity and reactogenicity of ten-valent versus 13-valent pneumococcal conjugate vaccines among infants in Ho Chi Minh City, Vietnam: a randomised controlled trial.
Temple B, Toan NT, Dai VTT, Bright K, Licciardi PV, Marimla RA, Nguyen CD, Uyen DY, Balloch A, Huu TN, Mulholland EK
Lancet Infect Dis, 19(5):497-509, 08 Apr 2019
Cited by: 22 articles | PMID: 30975525 | PMCID: PMC6484092
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation.
Dagan R
Expert Rev Vaccines, 18(6):641-661, 22 Jun 2019
Cited by: 16 articles | PMID: 31230486
Add to export list Review
PCV7- and PCV10-Vaccinated Otitis-Prone Children in New Zealand Have Similar Pneumococcal and Haemophilus influenzae Densities in Their Nasopharynx and Middle Ear.
de Gier C, Granland CM, Pickering JL, Walls T, Bhuiyan M, Mills N, Richmond PC, Best EJ, Thornton RB, Kirkham LS
Vaccines (Basel), 7(1):E14, 31 Jan 2019
Cited by: 7 articles | PMID: 30708945 | PMCID: PMC6466140
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Comparison of early effects of pneumococcal conjugate vaccines: PCV7, PCV10 and PCV13 on Streptococcus pneumoniae nasopharyngeal carriage in a population based study; The Palestinian-Israeli Collaborative Research (PICR).
Abu Seir R, Azmi K, Hamdan A, Namouz H, Jaar F, Jaber H, Rubin C, Doron D, Rahav G, Abdeen Z, Regev-Yochay G
PLoS One, 13(11):e0206927, 12 Nov 2018
Cited by: 7 articles | PMID: 30418989 | PMCID: PMC6231627
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Effectiveness and impact of the 10-valent pneumococcal conjugate vaccine, PHiD-CV: review of clinical trials and post-marketing experience.
Mrkvan T, Pelton SI, Ruiz-Guiñazú J, Palmu AA, Borys D
Expert Rev Vaccines, 17(9):797-818, 01 Sep 2018
Cited by: 9 articles | PMID: 30185083
Add to export list Review
Serotype-Specific IgG Antibody Waning after Pneumococcal Conjugate Primary Series Vaccinations with either the 10-Valent or the 13-Valent Vaccine.
van Westen E, Knol MJ, Wijmenga-Monsuur AJ, Tcherniaeva I, Schouls LM, Sanders EAM, van Els CACM, Berbers GAM, Rots NY
Vaccines (Basel), 6(4):E82, 11 Dec 2018
Cited by: 10 articles | PMID: 30544898 | PMCID: PMC6313931
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Continued occurrence of serotype 1 pneumococcal meningitis in two regions located in the meningitis belt in Ghana five years after introduction of 13-valent pneumococcal conjugate vaccine.
Bozio CH, Abdul-Karim A, Abenyeri J, Abubakari B, Ofosu W, Zoya J, Ouattara M, Srinivasan V, Vuong JT, Opare D, Asiedu-Bekoe F, Lessa FC
PLoS One, 13(9):e0203205, 07 Sep 2018
Cited by: 20 articles | PMID: 30192772 | PMCID: PMC6128537
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution.
Izurieta P, Bahety P, Adegbola R, Clarke C, Hoet B
Expert Rev Vaccines, 17(6):479-493, 29 Jun 2018
Cited by: 45 articles | PMID: 29241390
Add to export list Review
A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand.
Varghese L, Talbot L, Govender A, Zhang XH, Mungall BA
Appl Health Econ Health Policy, 16(3):331-345, 01 Jun 2018
Cited by: 2 articles | PMID: 29633160 | PMCID: PMC5940727
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 139 results

1 2 3 Next ...

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development.

Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.

Anticipated Effects of Higher-valency Pneumococcal Conjugate Vaccines on Colonization and Acute Otitis Media.

Immunogenicity of Current and Next-Generation Pneumococcal Conjugate Vaccines in Children: Current Challenges and Upcoming Opportunities.

Immunogenicity and seroefficacy of 10-valent and 13-valent pneumococcal conjugate vaccines: a systematic review and network meta-analysis of individual participant data.

Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults.

[The new 15-valent pneumococcal conjugate vaccine for the prevention of S. pneumoniae infections in pediatric age: a Health Technology Assessment].

Validation of an FFF-MALS Method to Characterize the Production and Functionalization of Outer-Membrane Vesicles for Conjugate Vaccines.

A cost-effectiveness analysis of PHiD-CV compared to PCV13 in a national immunization program setting in Tunisia.

Immunogenicity of Conjugated and Polysaccharide Pneumococcal Vaccines Administered During Pregnancy or Postpartum to Women With HIV.

Immunogenicity of alternative ten-valent pneumococcal conjugate vaccine schedules in infants in Ho Chi Minh City, Vietnam: results from a single-blind, parallel-group, open-label, randomised, controlled trial.

Cost-Effectiveness and Budget Impact Analyses of Pneumococcal Vaccination in Indonesia.

Cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine for children in Taiwan.

How Basic Immunological Principles May Instruct the Design of a Successful HIV-Type 1 Vaccine.

Cost-effectiveness of childhood pneumococcal vaccination program in Ethiopia: results from a quasi-experimental evaluation.

Spatial analysis of pneumococcal meningitis in São Paulo in the pre- and post-immunization era.

Immunogenicity and reactogenicity of ten-valent versus 13-valent pneumococcal conjugate vaccines among infants in Ho Chi Minh City, Vietnam: a randomised controlled trial.

Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation.

PCV7- and PCV10-Vaccinated Otitis-Prone Children in New Zealand Have Similar Pneumococcal and Haemophilus influenzae Densities in Their Nasopharynx and Middle Ear.

Comparison of early effects of pneumococcal conjugate vaccines: PCV7, PCV10 and PCV13 on Streptococcus pneumoniae nasopharyngeal carriage in a population based study; The Palestinian-Israeli Collaborative Research (PICR).

Effectiveness and impact of the 10-valent pneumococcal conjugate vaccine, PHiD-CV: review of clinical trials and post-marketing experience.

Serotype-Specific IgG Antibody Waning after Pneumococcal Conjugate Primary Series Vaccinations with either the 10-Valent or the 13-Valent Vaccine.

Continued occurrence of serotype 1 pneumococcal meningitis in two regions located in the meningitis belt in Ghana five years after introduction of 13-valent pneumococcal conjugate vaccine.

Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution.

A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand.

Partnerships & funding